PARP3

AcronymDefinition
PARP3Poly ADP (Adenosine Diphosphate)-Ribose Polymerase 3
References in periodicals archive ?
According to the company, rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed for advanced ovarian cancer.
Rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed in multiple tumor types, including ovarian, metastatic castration-resistant prostate, and bladder cancers, as monotherapy, and in combination with other anti-cancer agents.
Rucaparib is an oral, small molecule inhibitor of poly ADP-ribose polymerase 1 (PARP1), PARP2 and PARP3. PARP is a family of proteins involved in a number of critical cellular processes and is a key facilitator of DNA repair implicated in pathways of tumorigenesis.